Thrombosis and Atherosclerosis Research Institute, 237 Barton Street E, Hamilton, ON L9L 2X2, Canada.
Department of Chemistry and Chemical Biology, McMaster University, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.
Int J Mol Sci. 2021 Feb 23;22(4):2206. doi: 10.3390/ijms22042206.
Macrophages are present in nearly all vertebrate tissues, where they respond to a complex variety of regulatory signals to coordinate immune functions involved in tissue development, metabolism, homeostasis, and repair. Glycogen synthase kinase 3 (GSK3) is a ubiquitously expressed protein kinase that plays important roles in multiple pathways involved in cell metabolism. Dysregulation of GSK3 has been implicated in several prevalent metabolic disorders, and recent findings have highlighted the importance of GSK3 activity in the regulation of macrophages, especially with respect to the initiation of specific pathologies. This makes GSK3 a potential therapeutic target for the development of novel drugs to modulate immunometabolic responses. Here, we summarize recent findings that have contributed to our understanding of how GSK3 regulates macrophage function, and we discuss the role of GSK3 in the development of metabolic disorders and diseases.
巨噬细胞存在于几乎所有脊椎动物组织中,在那里它们响应复杂多样的调节信号,以协调参与组织发育、代谢、内稳态和修复的免疫功能。糖原合酶激酶 3(GSK3)是一种广泛表达的蛋白激酶,在涉及细胞代谢的多条途径中发挥重要作用。GSK3 的失调与几种常见的代谢紊乱有关,最近的研究结果强调了 GSK3 活性在调节巨噬细胞中的重要性,特别是在启动特定病理方面。这使得 GSK3 成为开发新型药物调节免疫代谢反应的潜在治疗靶点。在这里,我们总结了最近的研究结果,这些结果有助于我们了解 GSK3 如何调节巨噬细胞功能,并讨论了 GSK3 在代谢紊乱和疾病发展中的作用。